Package 0006-5007-01

{"route": ["ORAL"], "spl_id": "237e7245-b6e8-40df-8d66-4bb122136834", "openfda": {"nui": ["N0000175463", "N0000009948", "N0000175460", "N0000175656", "N0000175462", "N0000009947"], "upc": ["0300065007014"], "unii": ["913P6LK81M", "2T8Q726O95", "OTT9J7900I"], "rxcui": ["2055813", "2055815"], "spl_set_id": ["cd1e9f84-607a-46d3-b01e-2736018d67b6"], "pharm_class_epc": ["Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Merck Sharp & Dohme LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (0006-5007-01)", "package_ndc": "0006-5007-01", "marketing_start_date": "20180720"}], "brand_name": "DELSTRIGO", "product_id": "0006-5007_237e7245-b6e8-40df-8d66-4bb122136834", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Non-Nucleoside Analog [EXT]", "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]"], "product_ndc": "0006-5007", "generic_name": "doravirine, lamivudine, and tenofovir disoproxil fumarate", "labeler_name": "Merck Sharp & Dohme LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DELSTRIGO", "active_ingredients": [{"name": "DORAVIRINE", "strength": "100 mg/1"}, {"name": "LAMIVUDINE", "strength": "300 mg/1"}, {"name": "TENOFOVIR DISOPROXIL FUMARATE", "strength": "300 mg/1"}], "application_number": "NDA210807", "marketing_category": "NDA", "marketing_start_date": "20180720", "listing_expiration_date": "20261231"}